← back to search

Xiaoxiang Guan

Harbin Medical University · CN
Area of research
Cancer Research · Oncology
Research interest
Research interests include Cancer-related Molecular Pathways, MicroRNA in disease regulation, RNA modifications and cancer, and Breast Cancer Treatment Studies.
h-index
43
citations
6,809
works
207
NIH funding
primary concept
email

Recent publications

Targeting Zfp36 to combat cardiac hypertrophy: Insights into ferroptosis pathways
Clinical and Translational Medicine 2025cited by 7position: middledoi
A novel feedback loop: CELF1/circ-CELF1/BRPF3/KAT7 in cardiac fibrosis
Acta Pharmaceutica Sinica B 2025cited by 2position: middledoi
CircNSD1 promotes cardiac fibrosis through targeting the miR-429-3p/SULF1/Wnt/β-catenin signaling pathway
Acta Pharmacologica Sinica 2024cited by 24position: middledoi
Hypoxia stimulates CTC-platelet cluster formation to promote breast cancer metastasis
iScience 2024cited by 8position: lastdoi
Cuproptosis engages in c-Myc-mediated breast cancer stemness
Journal of Translational Medicine 2023cited by 30position: lastdoi
Intratumoral lipid metabolic reprogramming as a pro-tumoral regulator in the tumor milieu
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2023cited by 16position: lastdoi
SOX2-OT induced by PAI-1 promotes triple-negative breast cancer cells metastasis by sponging miR-942-5p and activating PI3K/Akt signaling
Cellular and Molecular Life Sciences 2022cited by 42position: lastdoi
Corrigendum to “MiR-499a prevents astrocytes mediated inflammation in ischemic stroke by targeting PTEN” [Non-coding RNA Res. 6 (2021)146–152]
Non-coding RNA Research 2022cited by 1position: firstdoi
MiR-499a prevents astrocytes mediated inflammation in ischemic stroke by targeting PTEN
Non-coding RNA Research 2021cited by 9position: firstdoi
Microwave ablation of primary breast cancer inhibits metastatic progression in model mice via activation of natural killer cells
Cellular and Molecular Immunology 2020cited by 59position: middledoi
miR-106a promotes cardiac hypertrophy by targeting mitofusin 2
Journal of Molecular and Cellular Cardiology 2016cited by 73position: firstdoi
Maintenance Therapy With Immunomodulatory Drugs in Multiple Myeloma: A Meta-Analysis and Systematic Review
JNCI Journal of the National Cancer Institute 2015cited by 56position: middledoi
β-Blocker carvedilol protects cardiomyocytes against oxidative stress-induced apoptosis by up-regulating miR-133 expression
Journal of Molecular and Cellular Cardiology 2014cited by 113position: middledoi
miR-101 Promotes Breast Cancer Cell Apoptosis by Targeting Janus Kinase 2
Cellular Physiology and Biochemistry 2014cited by 69position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Chaoqian Xu · Ministry of Education of the People's Republic of China4 papers (2014–2024)Saidi Jin · Harbin Medical University3 papers (2024–2025)Xin Han · Wenzhou Medical University3 papers (2022–2024)Ying Lu · Jiangsu University2 papers (2014–2016)Yueyao Wu · Nanjing University of Chinese Medicine2 papers (2023–2024)Runtian Wang · Nanjing Medical University2 papers (2023–2023)Hongli Shan · Ministry of Education of the People's Republic of China2 papers (2014–2014)Qin Hu · Xinjiang Medical University2 papers (2023–2023)Wenzheng Cheng · Harbin Medical University2 papers (2025–2025)Xiaofei Guo · Harbin Medical University2 papers (2016–2025)Bowen Zhang · Fudan University2 papers (2025–2025)Mingyu Zhang · Harbin University of Science and Technology2 papers (2024–2025)Wenwen Zhang · Northeast Agricultural University2 papers (2015–2022)Yiwei Zhang · Hubei University of Medicine2 papers (2021–2022)Baofeng Yang · Shenyang Pharmaceutical University2 papers (2014–2016)Zhimin Du · The First Affiliated Hospital, Sun Yat-sen University2 papers (2024–2025)Dongni Ji · Harbin Medical University2 papers (2024–2025)Ozal Beylerli · Harbin Medical University2 papers (2021–2022)Yuan Jiang · Harbin Medical University2 papers (2024–2025)Jacqueline Wang · NYU Langone Health2 papers (2015–2024)